Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

Deborah Grayson, a top pharmacist and nutritional therapist, has warned that weight loss medication can cause an inflamed ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...

Women who have quickly lost weight say strangers are now more likely to smile at them or strike up a conversation.

Investing.com -- Hims & Hers Health shares are down over 8% premarket Thursday after a federal judge ruled in favor of the ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Both semaglutide and tirzepatide should help people with Type 2 diabetes lower their HbA1c, a measure of blood glucose over ...

While one study found lower rates of preterm birth alongside higher rates of hypertensive disorders, another found fewer ...